James C. Melvin

• -Leader/Co-Architect of a profound business turnaround in the US.
• -Implemented a strong culture of accountability and excellence in execution, leading to a dramatic turnaround of the US Medical Dermatology Business. Through increased rigor in effective clinical messaging, and flawless call plan precision, changed the performance trajectory of our AD Biologic Medication in the US (~93M USD in 2023, to ~160M in 2025).
• -Achieved and maintained the highest employee engagement scores (~90%), and retention rates of our 70th percentile performers through consistent high-touch communication strategies.
• -Successfully positioned the US Business for additional product launches and partnerships by consistently exceeding top-line sales targets, demonstrating excellence in execution, while simultaneously partnering with cross-functional colleagues to reduce the cost-basis in the US.

• - Led the development and execution of go-to-market plan for +$10B Immunology Brand in the US.
• - Built and Led Large Sales, and Business Operations Support Teams, helping delivering efficiencies and profitable results for the organization and effective outcomes for patients.
• -Led Multiple Business Operations Functions in support of the annual execution of the Dupixent Brand Plan, as well as the long-term strategic planning for the Brand.
• -Drove Innovation with the development and implementation of unique Incentive Plans and Machine Learning Models to elevate engagement and improve efficiency in execution.

Successful Sales Representative, District Manager, Sales Representative, Operations Director, Marketing Director, Head of Sales Incentive Compensation/Field Force Analytics, Head of Leadership Training and Development